BREAST NEOPLASM
Clinical trials for BREAST NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new BREAST NEOPLASM trials appear
Sign up with your email to follow new studies for BREAST NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for breast cancer patients when standard drugs fail
Disease control OngoingThis study is for people with a specific type of advanced breast cancer that has continued to grow despite previous hormone therapy and a targeted drug. It tests whether adding a medication called abemaciclib to standard fulvestrant therapy is better at controlling the cancer tha…
Matched conditions: BREAST NEOPLASM
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New radiation technique aims to protect hearts of breast cancer patients
Disease control OngoingThis study is testing whether a newer type of radiation called proton therapy can reduce long-term side effects for women with stage II or III breast cancer who need radiation after surgery. The goal is to see if this method lowers the risk of future heart problems and second can…
Matched conditions: BREAST NEOPLASM
Phase: PHASE2 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for Tough-to-Treat breast cancer: testing a drug after standard chemo fails
Disease control OngoingThis study is testing whether the drug trifluridine/tipiracil can help control advanced breast cancer that has stopped responding to standard chemotherapy. It is for women with a specific type (ER-positive, HER2-negative) who have already been treated with two common chemo drugs.…
Matched conditions: BREAST NEOPLASM
Phase: PHASE2 • Sponsor: Borstkanker Onderzoek Groep • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Tracking the pain: scientists map nerve damage from common breast cancer treatment
Knowledge-focused OngoingThis study aims to understand how and why the breast cancer drug T-DM1 causes nerve damage (peripheral neuropathy) in patients. Researchers will observe 36 patients with HER2-positive breast cancer who are receiving T-DM1 treatment. They will track changes in nerve-related sympto…
Matched conditions: BREAST NEOPLASM
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
New website aims to guide cancer patients through tough fertility choices
Knowledge-focused OngoingThis study is testing a special website designed to help young women recently diagnosed with cancer make decisions about preserving their fertility. Cancer treatments can sometimes affect a woman's ability to have children later, and this tool provides information to help them un…
Matched conditions: BREAST NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
New scan could help doctors see if breast cancer drugs are working
Knowledge-focused OngoingThis study is testing a new type of PET/CT scan to see if it can show how breast cancer tumors respond to a combination of two drugs. Researchers want to see if changes on the scan early in treatment can predict how well the patient will do later. The study involves about 20 peop…
Matched conditions: BREAST NEOPLASM
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC
-
Scientists test new scan to see inside breast cancer cells
Knowledge-focused OngoingThis study is testing whether a new imaging tracer called [18F]ISO-1 can help doctors see specific features inside breast cancer cells using PET/CT scans. Researchers will scan 30 adults with breast cancer to see if the imaging results match what's found in tissue samples. The go…
Matched conditions: BREAST NEOPLASM
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:27 UTC